MaryEHartnettMD

PubMed

• 174 citations
  Classification of retinal pigment epithelial detachments associated with drusen.
  M. Elizabeth Hartnett, John J. Weiter, Armando Garsd, Alex E. Jalkh
  Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1992-01-01
• 152 citations
  Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders.
  Richard F. Spaide, Chui Ming Gemmy Cheung, Hidetaka Matsumoto, Shoji Kishi, Camiel J. F. Boon
  Progress in Retinal and Eye Research. 2021-05-21
• 1726 citations
  Global Causes of Blindness and Distance Vision Impairment 1990-2020: A Systematic Review and Meta-Analysis
  Seth Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite
  The Lancet. Global Health. 2017-12-01

Journal Articles

• Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients with Autosomal Dominant Retinitis Pigmentosa  
  David G Birch, Michael P Teske, Richard G Weleber, Robert Lindblad, Byron L Lam, Judith Warner, Gary Edd Fish, Neal L Sklaver, Mark E Pennesi, John Heckenlively, Paul ..., JAMA
• Role of cytokines and treatment algorithms in retinopathy of prematurity  
  Hartnett ME, Curr Opin Ophthalmol, 1/30/2017
• Protective effect of maternal uteroplacental insufficiency on oxygen-induced retinopathy in offspring: removing bias of premature birth  
  Becker S, Wang H, Yu B, Brown R, Han X, Lane RH, Hartnett ME, Sci Rep, 1/14/2017
• Can a Risk Factor Based Approach Safely Reduce Screening for Retinopathy of Prematurity?  
  Friddle KM, Yoder BA, Hartnett ME, Henry E, DiGeronimo RJ, Int J Pediatr, 1/1/2017
• Electroretinographic Responses in the Smallest Eyes  
  Hartnett ME, JAMA Ophthalmol, 1/1/2017
• Diabetic retinopathy, an overview  
  Hartnett, M.E., Baehr, W., & Le, Y.Z., Vision Res, 1/1/2017
• Familial exudative vitreoretinopathy presentation as persistent fetal vasculature  
  Kartchner, J.Z., & Hartnett, M.E., Am J Ophthalmol Case Rep, 1/1/2017
• Correspondence  
  Todorich, B., et al, Retina, 1/1/2017
• Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study  
  Wallace, D. K. et al, JAMA Ophthalmol, 1/1/2017
• Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific Effects  
  Wang, H., & Hartnett, M.E., Antioxidants, 1/1/2017
• Successful management of post-traumatic vancomycin-resistant enterococcus endophthalmitis  
  Nguyen, J. & Hartnett, M. E., American Journal of Ophthalmology, 1/1/2017
• Advances in understanding and management of retinopathy of prematurity  
  Hartnett, M. E., Surv Ophthalmol, 1/1/2017
• Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model  
  Becker, S., Wang, H., Stoddard, G. J. & Hartnett, M. E., Mol Vis, 1/1/2017
• Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy  
  Zhu, W., et al, J Clin Invest, 1/1/2017
• Association of Maternal Preeclampsia with Infant Risk of Premature Birth and Retinopathy of Prematurity  
  Schulman, J. P., Weng, C., Wilkes, J., Greene, T. & Hartnett, M. E., JAMA Ophthalmol, 1/1/2017
• Regulation of signaling events involved in the pathophysiology of neovascular AMD  
  Wang H, Hartnett ME, Mol Vis, 1/27/2016
• Retinal Pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization  
  Wang H, Han X, Bretz CA, Becker S, Gambhir D, Smith GW, Samulski RJ, Wittchen ES, Quilliam LA, ChrzanowskaoWodnicka M, Hartnett ME, Mol Ther Methods Clin Dev, 1/24/2016
• Advances in diagnosis, clinical care, research, and treatment in retinopathy of prematurity  
  Hartnett ME, Capone Jr A, Eye and Brain, 1/19/2016
• Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization  
  Wang H, Han X, Gambhir D, Becker S, Kunz E, Liu AJ, Hartnett ME, PLoS One, 1/16/2016
•  
  Wang H, Han X, Wittchen ES, Hartnett ME, Mol Vis, 1/3/2016
• How glaucoma patient characterisitics, self-efficacy and patient-provider communication are associated with eye drop technique  
  Sayner R, Carpenter DM, Blalock SJ, Robin AL, Muir KW, Hartnett ME, Giangiacomo AL, Tudor G, Goldsmith JA, Sleath B, Int J Pharm Pract, 1/1/2016
• The Effect of Eye Drop Technique Education in Patients With Glaucoma  
  Carpenter DM, Sayner R, Blalock SJ, Muir KW, Hartnett ME, Lawrence SD, Giangiacomo AL, Goldsmith JA, Tudor GE, Robin AL, Sleath BL, Health Commun, 1/1/2016
• Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration  
  Wang H, Han X, Kunz E, Hartnett ME, Invest Ophthalmol Vis Sci, 1/1/2016
• case of coats disease and concurrent anisometric amblyopia  
  Lambert NG, Hoffman RO, Hartnett ME, American Journal of Ophthalmology, 1/1/2016
• Advances in Understanding and Management of Retinopathy of Prematurity  
  Hartnett, ME, Surv. Ophthalmol, 1/1/2016
• Join now to see all

Books/Book Chapters

• Pathophysiology of ROP. Retinopathy of Prematurity 
  Hartnett MEEditors: Andres Kychenthal and Paola Dorta.Springer Science and Business Media, New York, NY2016
• The Effects of Hypoxia, Hyperoxia, and Oxygen Fluctuations on Oxidative Signaling in the Preterm Infant and Retinopathy of Prematurity. Oxidative Stress and Antioxidant Protection. The Science of Free Radical Biology and Disease 
  Hartnett MEEditors: Donald Armstrong and Robert D. Stratton.John Wiley and Sons, Inc., Hoboken, NJ2016
• Pediatric Retina 
  Chapter: Clinical Trials and Management of Severe Retinopathy of Prematurity 
  Page 492 - 512Hartnett ME, Shulman JPEditors: ME Hartnett.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2014
• Pediatric Retina 
  Chapter: Oxidative Stress and Signaling Pathways Involved in Developmental and Aberrant Angiogenesis Relating to Retinopathy of Prematurity 
  Page 555 - 567Hartnett ME, Wang HEditors: ME Hartnett.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2014
• Pediatric Retina 
  Chapter: Treatment of Stages 4 and 5 Retinopathy of Prematurity 
  Page 597 - 603Hartnett ME, Capone A, Trese MTEditors: ME Hartnett.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2014
• Pediatric Retina 
  Chapter: Flecks and Spots 
  Page 746 - 767Hartnett ME, Trese MT, Capone AEditors: ME Hartnett.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2014
• The New Visual Neurosciences 
  Chapter: Retinopathy of Prematurity:� A Template for Studying Retinal Vascular Disease 
  Page 1483 - 1501Hartnett MEEditors: JS Werner & LM Chalupa.The MIT Press, Cambridge, MA2014
• Pediatric Retina 
  Editors: Hartnett ME.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2014
• Studies on Retinal and Choroidal Disorders 
  Chapter: The Role of Reactive Oxygen Species and Oxidative Signaling in Retinopathy of Prematurity 
  Page 559 - 584Hartnett ME, DeAngelis, MMEditors: R.D. Stratton, W.W. Hauswirth, & T.W. Gardener.Springer, New York, NY2012
• Ocular Disease: Mechanisms and Management 
  Chapter: Retinopathy of Prematurity 
  Page 562 - 571Hartnett ME, Toth CAEditors: L.A. Levin and D.A. Albert.Saunders/Elsevier, Philadelphia, PA2010
• Encyclopedia of the Eye 
  Chapter: Retinal vasculopathies: retinopathy of prematurity 
  Hartnett MEEditors: R Hodges, D Dartt, & D Bok.Elsevier/Academic Press, Amsterdam, The Netherlands2010
• Encyclopedia of the Eye 
  Chapter: Breakdown of the blood: retinal pigmented epithelium barrier 
  Hartnett MEEditors: R Hodges, D Dartt, & P D'Amore.Elsevier/Academic Press, Amsterdam, The Netherlands2010
• Pediatric Retina 
  Editors: Hartnett ME.Lippincott Williams & Wilkins, Philadelphia, PA2005
• Pediatric Retina 
  Chapter: Treatment of Retinopathy of Prematurity: Peripheral Retinal Ablation and Vitreoretinal Surgery 
  Page 417 - 424Capone A., Hartnett ME, Trese MTEditors: ME Hartnett.Lippincott Williams & Wilkins, Philadelphia, PA2005
• Pediatric Retina 
  Chapter: Retinopathy of Prematurity: Current Understanding Based on Clinical trials and Animal Models 
  Page 387 - 49McColm J, Hartnett MEEditors: ME Hartnett.Lippincott Williams & Wilkins, Philadelphia, PA2005
• Retina 
  Chapter: Pathogenetic Mechanisms of Retinal Detachment 
  Page 2013 - 2020Oh K, Hartnett ME, Landers MLEditors: Ryan.Mosby, Inc., St. Louis, MOEdition 4th,2005
• Clinical Pathways in Vitreoretinal Disease 
  Editors: Steidl S, Hartnett ME.Thieme Publishers, New York, NY2003
• Clinical Pathways in Vitreoretinal Disease 
  Chapter: Diagnosis and Examination of the Pediatric Patient 
  Page 341 - 373Hartnett MEEditors: S Steidl, ME Hartnett.Thieme Publishers, New York, NY2003
• Schepens� Retinal Detachment and Allied Diseases 
  Chapter: Macular breaks and other macular changes 
  Page 435 - 455Schepens CL, Hartnett MEEditors: CL Schepens, ME Hartnett, T Hirose.Butterworth-Heinemann, Boston, MAEdition 2nd,2000
• Schepens� Retinal Detachment and Allied Diseases 
  Editors: Schepens CL, Hartnett ME, Hirose T.Butterworth-Heinemann, Boston, MA2000
• Schepens� Retinal Detachment and Allied Diseases 
  Chapter: Basic considerations of preoperative patient management and technical aspects of chorioretinal adhesion 
  Page 257 - 270Hartnett MEEditors: CL Schepens, ME Hartnett, T Hirose.Butterworth-Heinemann, Boston, MAEdition 2nd,2000
• Schepens� Retinal Detachment and Allied Diseases 
  Chapter: Complications 
  Page 721 - 740Hartnett MEEditors: CL Schepens, ME Hartnett, T Hirose.Butterworth-Heinemann, Boston, MAEdition 2nd,2000
• Schepens� Retinal Detachment and Allied Diseases 
  Chapter: Evaluation of the traumatized eye 
  Page 679 - 687Hartnett MEEditors: CL Schepens, ME Hartnett, T Hirose.Butterworth-Heinemann, Boston, MAEdition 2nd,2000
• Schepens� Retinal Detachment and Allied Diseases 
  Chapter: Prophylaxis of retinal detachment 
  Page 271 - 288Hartnett MEEditors: CL Schepens, ME Hartnett, T Hirose.Butterworth-Heinemann, Boston, MAEdition 2nd,2000
• Schepens� Retinal Detachment and Allied Diseases 
  Chapter: Managing the crystalline lens and intraocular lenses 
  Page 555 - 565Hartnett MEEditors: CL Schepens, ME Hartnett, T Hirose.Butterworth-Heinemann, Boston, MAEdition 2nd,2000
• Join now to see all

Abstracts/Posters

• Specific Knockdown of Muller Cell Vascular Endothelial Growth Factor (VEGF) thins Photoreceptors without reducing Retinal Function via Increased Expression of Retinal ...
  Hartnett ME, Macula Society Annual Meeting, Beverly Hills, CA, 1/1/2018
• Clinical Trials on Anti-VEGF and other therapies in diabetic retinopathy
  Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Baltimore, MD, 1/1/2017
• Constitutive erythropoietin receptor signaling exacerbates pathologic choroidal neovascularization in an animal model
  Eric Kunz, Colin A. Bretz, V. Divoky, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Baltimore, MD, 1/1/2017
• Inhibition of Uncoupling Protein 2 Promotes Physiologic Retinal Vascularization via Activation of GLUT1 and S6K1
  Xiaokun Han, Haibo Wang, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Baltimore, MD, 1/1/2017
• Analysis of Wnt pathway components during combined intrauterine growth restriction and oxygen-induced retinopathy
  Silke Becker, R. Brown, A. Brown, C. Fung, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Baltimore, MD, 1/1/2017
• Innovative Experimental Model to Detect Protective Factors against Retinopathy of Prematurity
  Hartnett ME, Retina Society Annual Meeting, Boston, MA, 1/1/2017
• Diagnosis and Management of Pediatric Retina Dilemmas
  Lejla Vajzovic, Caroline R Baumal, Audina M Berrocal, Mary Elizabeth Hartnett, Anna L Ells, AAO Annual Meeting, New Orleans, LA, 1/1/2017
• Paul Henkind Memorial Lecture, �Angiogenesis, Anti-VEGF and Anti-Angiogenic Strategies
  Hartnett ME, Macula Society, Miami Beach, FL, 1/1/2016
• Inhibition of Uncoupling Protein 2 Promotes Postnatal Growth and Physiologic Retinal Vascular Development in a Rat Model of Oxygen Induced Retinopathy
  Xiaokun Han, Angelina Jingtong Liu, Eric Kunz, Colin A. Bretz, Hartnett ME, Haibo Wang, The Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA, 1/1/2016
• Neovascular changes and Angiogeic Factor Production During Combined Intrauterine Growth Restriction and Oxygen-Induced retinopathy
  Silke Becker, Haibo Wang, Baifeng Yu, Robert H. Lane, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), 1/1/2016
• Thy-1Induces Activation and Migration of Choroidal Endothelial Cells: Relevance to Neovascular Age-related Macular Degeneration
  Hartnett ME, The Retina Society; Research in Vision and Ophthalmology (ARVO), San Diego, CA, 2016; Seattle, WA, 2016, 1/1/2016
• Thy-1 regulates VEGF-induced choroidal endothelial cell migration
  Wang H, Jiang Y, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Orlando, FL, 1/1/2014
• Inhibition of endothelial growth factor splice variant inhibits pathologic neovascularization safely in model of retinopathy of prematurity
  Jiang Y, Wang H, Culp D, Yang Z, Fotheringham L, Flannery J, Hammond S, Kafri T, Hartnett ME, American Ophthalmological Society (AOS), New York City, NY, 1/1/2014
• Muller cell derived VEGF164 knockdown reduces retinal neovascularisation in the rat model of retinopathy of prematurity
  Gambhir D, Jiang Y, Smith GW, Yang Z, Wang H, Fotheringham L, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Orlando, FL, 1/1/2014
• Inhibition of Vascular Endothelial Growth Factor Splice Variant Inhibits Pathologic Neovascularization Safely in Model of Retinopathy of Prematurity
  Hartnett ME, American Ophthalmological Society (AOS) Annual Meeting, New York City, NY, 1/1/2014
• The combined effect with Erythropoietin and VEGF in retinal angiogenesis
  Yang Z, Wang H, Jiang Y, Mccloskey M, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA, 1/1/2013
• Candidate Gene Study of Retinopathy of Prematurity in Extremely Low Birthweight Infants from the Neonatal Research Network
  Hartnett ME, Morrison M, Page G, Cotten M, Murray J, DeAngelis M, The Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA, 1/1/2013
• Activation of Rap1 prevents tumor necrosis factor alpha-induced ROS generation in RPE
  Wang H, McCloskey M, Wittchen ES, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA, 1/1/2013
• Knockdown of M�ller cell specific VEGF reduces retinal neovascularization in a rat model of retinopathy of prematurity
  Jiang Y, McCloskey M, Wang H, Yang Z, Strange J, Kafir T, Flannery JG, Greenberg K, Hammond S, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA, 1/1/2013
• 8-CPT-2-O-Me-cAMP, a Rap1 activator, suppresses laser-induced CNV in Mice
  Nishimura E, McCloskey M, Jiang Y, Smith GW, Wang H, Wittchen ES, Koide R, Hartnett ME, The Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 1/1/2012
• Decreased IGF1 Expression Asociated with Avascular Retina in Model of Retinopathy of Prematurity
  Jiang Y, Numpang B, Yu Baifeng, Wang Haibo, Smith GW, McCloskey M, Patel S, DiGeroniimo R, Hartnett ME, Lane R, The Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 1/1/2012
• The small GTPase Rap1 regulates intracellular ROS generation in RPE
  Wang H, Wittchen ES, Shi D, Li DY, Hartnett ME, The Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 1/1/2012
• Activation of Rap1 reduces Reactive Oxygen Species in Retinal Pigment Epithelium and Choroidal Neovascularization in an Animal Model
  Wang H, Nishimura E, McCloskey M, Wittchen ES, Hartnett ME, The American Ophthalmology Society (AOS), Charleston, SC, 1/1/2012
• VEGF Mediated Stat3 Activation Contributes to Retinal Avascularity in Rat Model of ROP
  Hartnett ME, Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 1/1/2011
• Rap1 GTPass Is Involved In RPE Cell Barrier Function
  Wittchen ES, Burridge K, Hartnett ME, 1/1/2011
• Join now to see all

Lectures

• Retinopathy of Prematurity 
  Muliple presentations, 1990, 1994, 1995, 1997, 2001, 2002, 2005, 2008, 2010,2011, 2012, 2018 - 1/1/2018
• Angiogenesis in Ocular Diseases 
  1/1/2018
• Activation of Neuroprotective Mechanisms after Inhibition of VEGF in Retinopathy models 
  Cabo San Lucas, Mexico - 1/1/2018
• Discovering mechanisms in the changing and Diverse pathology of ROP 
  Honolulu, HI - 1/1/2018
• Neuro and Glial-Vascular Effects in the Pathogenesis of Diabetic Retinopathy 
  Orlando, FL - 1/1/2018
• IQGAP1 Regulates VEGF-induced Choroidal Endothelial Cell Migration through Rac1 
  Northern Ireland, United Kingdom, 2018; Vienna, Austria, 2018 - 1/1/2018
• Anti-VEGF Treatment for ROP: Clinical Trials and Phenotypic Differences Worldwide 
  Chicago, IL - 1/1/2018
• Diagnosis and management of pediatric retina dilemmas 
  Chicago, IL - 1/1/2018
• Update on Retinopathy of Prematurity 
  1/1/2018
• Diabetic Retinopathy Part 1 
  1/1/2017
• Retinopathy of Prematurity Diagnosis and Management 
  Lima, Peru - 1/1/2017
• What�s New in Diabetic Retinopathy: Updates for the Endocrinologist? 
  The University of Utah, Salt Lake City, UT - 1/1/2017
• Generating a Hypothesis 
  1/1/2016
• Experimental Models of Retinopathy Based on Preterm Infant Stress 
  Los Cabos, Mexico - 1/1/2016
• Pediatric Retina: Pearls to Diagnose and Treat Retinopathy of Prematurity 
  Vancouver, Canada - 1/1/2016
• Studying Effects of Intrauterine Growth Restriction on Retinopathy of Prematurity with Rodent Models 
  Tokyo, Japan - 1/1/2016
• Thy-1 Activated Choroidal Endothelial Cell: Relevance to AMD 
  San Diego, CA - 1/1/2016
• Women�s Eye Health 
  1/1/2015
•  
  Paris, France - 1/1/2015
• Rationale, Evidence and Safety for Anti VEGF in Proliferative Angiogenesis 
  Vienna, Austria - 1/1/2015
• Mechanisms of Aberrant Angiogenesis 
  1/1/2015
• Mechanisms of Anti-VEGF and Prospects for Future Treatments of ROP 
  Las Vegas, NV - 1/1/2015
• Eye Health in Women 
  The University of Utah, Salt Lake City, UT - 1/1/2015
• Pediatric Retina 
  1/1/2014
• AMD 
  1/1/2014
• Join now to see all

Other

• Stickler Syndrome 
  Hartnett, ME, Moran CORE
  http://morancore.utah.edu/section-12-retina-and-vitreous/stickler-syndrome/
  1/1/2018
• Choroideremia 
  Hartnett, ME, Moran CORE
  http://morancore.utah.edu/section-12-retina-and-vitreous/choroideremia-2/
  1/1/2018
• Retinopathy of Prematurity (ROP) 
  Hartnett, ME, Moran CORE
  http://morancore.utah.edu/section-12-retina-and-vitreous/retinopathy-of-prematurity-rop/
  1/1/2017
• Familial Exudative Vitreoretinopathy (FEVR) 
  Hartnett, ME, Moran CORE
  http://morancore.utah.edu/section-12-retina-and-vitreous/familial-exudative-vitreoretinopathyfevr/
  1/1/2017
• Incontinentia Pigmenti 
  Hartnett, ME, Moran CORE
  http://morancore.utah.edu/section-12-retina-and-vitreous/incontinentia-pigmenti/
  1/1/2017
• Breakdown of the Retinal Pigmented Epithelium Blood-Retinal Barrier 
  Hartnett ME, Sciencedirect
  1/1/2017
• Researchers Identify Protein that Plays Key Role in Diabetic Blindness 
  Zhu Wendy, Li Dean, Hartnett ME, Odelberg Shannon, University of Utah Press Release
  1/1/2017
• Coats Disease 
  Hartnett, ME, Moran CORE
  http://morancore.utah.edu/section-12-retina-and-vitreous/coats-disease/
  1/1/2017
• Central Serous Chorioretinopathy � Case Report 
  Vegunta S, Hwang ES, Hartnett ME
  1/1/2015
• Advancing technology helpful in pediatric retinal ophthalmology cases 
  Hartnett ME, Ocular Surgery News
  1/1/2010
• Invited article: Advancing technology helpful in pediatric retinal ophthalmology cases 
  Hartnett ME, Ophthalmic Surgery News
  1/1/2010
• Pharmacotherapy Targeting Ocular Neovascularization (invited publication) 
  Hartnett ME as consultant, Focal Points AAO
  1/1/2008
• Risk Factors in AMD: Insight from Studies on Environmental Risk Factors, Genotype, and VEGF (invited publication) 
  Hartnett ME, AMD Update/Ophthalmology Management
  1/1/2007
• Cutting-Edge Therapies for Wet AMD. Review: Therapeutic Topics (invited publication) 
  Abelson M, Hartnett ME, McLaughlin J, Review of Ophthalmology
  1/1/2006
• An investigation of retinal nonperfusion and its inhibition: A strategy to prevent proliferative diabetic retinopathy (invited publication) 
  Hartnett ME, Forefront.�American Diabetes
  1/1/2006
• Differences in Perceived Barriers to Diabetic Eye Care (invited publication) 
  Hartnett ME, Diabetic Microvascular Complications Today
  1/1/2005
• Lesion characteristics important in assessing therapies for AMD (invited publication) 
  Hartnett ME, Ocular Surgery News (Europe Asia-Pacific Edition adapted from USA version 16:6
  1/1/2005
• Retinopathy of prematurity is the common cause of infant blindness (invited publication) 
  Hartnett ME, Wallace D, UNC Health Care, featured in News 14 Carolina
  1/1/2004
• Managing retinopathy of prematurity (invited publication) 
  Hartnett ME, EyeNet Magazine
  1/1/2004
• AMD and the generalist (invited publication, also translated into Spanish and republished) 
  Hartnett ME, Review of Ophthalmology
  1/1/2004
• Pertinence of a vitreoretinal surgical simulator 
  Hartnett ME, Sixth Annual Dual-Use Technologies & Applications Conference
  Syracuse, NY - 1/1/1996
• Visual rehabilitation, presentation to occupational therapists, audio and video 
  Hartnett ME, Spaulding Rehabilitation Hospital
  1/1/1995
• Glaucoma as a cause of poor vision in severe retinopathy of prematurity (invited publication) 
  Hartnett ME, Hirose T, Gilbert MM, Richardson TM, Katsumi O, Ophthalmology Digest
  1/1/1994
• Current concepts in retinopathy of prematurity, presentations to vision teachers 
  Hartnett ME, Perkins School for the Blind
  Boston, MA - 1/1/1994
• Join now to see all